New Issue: Science’s Impossible Questions. Read Now

30 under 30: Paving the Way for Medical Nanorobots

Meet Aniket Magarkar, one of the promising young chemists attending the 2013 Lindau Nobel Laureate Meeting

Join Our Community of Science Lovers!

Each year hundreds of the best and brightest researchers gather in Lindau, Germany, for the Nobel Laureate Meeting. There, the newest generation of scientists mingles with Nobel Prize winners and discusses their work and ideas. The 2013 meeting is dedicated to chemistry and will involve young researchers from 78 different countries. In anticipation of the event, which will take place from June 30 through July 5, we are highlighting a group of attendees under 30 who represent the future of chemistry. The following profile is the 11th in a series of 30.

Name: Aniket Magarkar
Age: 28
Born: Amaravati, India
Nationality: Indian

Current position: PhD Student in Computational Nanomedicine at the University of Helsinki, Finland
Education: Bachelor’s degree in biotechnology from the University of Mumbai, India; Master’s degree in bioinformatics from the University of Pune, India


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


What is your field of research?
I am investigating in silico approaches to hypothesis-driven drug delivery. I am dealing with drug delivery liposomes [essentially artificial bubbles composed of lipids] surface structures and their interactions with elements of the bloodstream and small molecules. Once these structures and interactions are understood at the atomic level, that knowledge will help scientists build advanced nanorobots for future drug delivery.

What drew you to chemistry, and to that research area in particular?
I was fascinated with the amount of interactions going on in biological cells and I wanted to understand them in detail. I believe chemistry is the language of biology, and in order to understand biological principles, one needs to know the laws of chemical interactions and physical chemistry better. This drew me toward research in general. Later, I decided to move into computational modeling and data mining of biochemical structures. This field allows me to test many hypotheses quickly. Hence I decided to pursue computational chemistry and modeling for my research.

Where do you see yourself in 10 years?
It is really difficult to say right now as the science is evolving at a phenomenal pace. However, I would like to be involved in multi-dimensional research in systemic biology, an area where I could contribute my expertise in drug discovery and delivery toward tackling new strategies to fight diseases in a smarter way.

Who are your scientific heroes?
Craig Venter, Michael Faraday, Robert Langer and Francis Crick

What is your dream study or experiment? If you had unlimited resources, what kind of research would you conduct?
I would like to understand the process of synchronization among the interactions of the biological cell’s chemical components. I would like to re-create that process from the ground up—from making individual components—and then see it replicate.

What activities outside of chemistry do you most enjoy?
I like to play chess and Judo, and love spending my time with the latest gadgets—as I love technology a lot. Also, I like to travel and explore new areas and culture anywhere in the world!

What do you hope to gain from this year’s Lindau meeting?
I think the Lindau meeting is going to be an amazing experience. I will not only meet legends in the field of chemistry who changed the way we do research, but I will also have the opportunity to interact with young colleagues from around the world who are working in multidisciplinary backgrounds towards cohesive goals. I think it will be truly inspirational to just be at the meeting and hear about current trends in science as well as discuss them with laureates and discover future research directions.


Are there any Nobelists whom you are particularly excited to meet?
I would love to meet Brian Kobilka, who discovered G protein coupled receptors because that is an area of my research interest. I am also looking forward to seeing Walter Gilbert for his nonconventional DNA sequencing method, Edmond Fischer for discovering biological switch points of phosphorylation, John Walker for figuring out ATP synthesis and Ada Yonath for discovering the structure of the ribosome. All of these were crucial discoveries, I think, without which our understanding of biology would have been limited—I am excited to meet all of them.

 

« Previous 10. Evelyn Auyeung

30 Under 30: Lindau Nobel Laureate Meeting

Next » 12. Thomas Lunkenbein

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe